Toregem Biopharma

PharmaceuticalsSeries BJapantoregem.co.jp

Latest round

Series B

Last raised

Aug 2024

Total raised

$13M

Investors

6

About Toregem Biopharma

Founded in 2020 and based in Kyoto, Japan, Toregem Biopharma operates as a researcher and developer of antibiotic drugs that help with tooth regeneration., Ltd. and SHOFU INC. and JIC Venture Growth Investments. The firm develops and offers treatment for patients with congenital tooth loss and other dental anomalies, ultimately providing solutions for those with tooth defects. The company seeks to deliver therapies that promote tooth growth from patients' own tissues, thereby enhancing quality of life through improved dental health.

Who invested in Toregem Biopharma

6 investors across 4 rounds

See all investors in Toregem Biopharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 30, 2024

    Amount

    $10M

    Investors

    Locked

  2. Series B

    Jul 3, 2023

    Amount

    $2.6M

    Investors

    Locked

  3. Series A

    May 6, 2021

    Amount

    $0.1M

    Investors

    Locked

  4. Series A

    Sep 3, 2020

    Amount

    $0.5M

    Investors

    Locked

Questions about Toregem Biopharma

Who invested in Toregem Biopharma?

Toregem Biopharma has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Toregem Biopharma raised?

Toregem Biopharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Toregem Biopharma last raise money?

Toregem Biopharma's most recent round on record is a Series B, in Aug 2024.

What does Toregem Biopharma do?

Founded in 2020 and based in Kyoto, Japan, Toregem Biopharma operates as a researcher and developer of antibiotic drugs that help with tooth regeneration.

Where is Toregem Biopharma headquartered?

Toregem Biopharma is headquartered in Japan.

Which VCs invest in companies like Toregem Biopharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Toregem Biopharma's stage. Their profiles are linked below.

Raising like Toregem Biopharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.